SOAR: Smartphones for Opiate Addiction Recovery

Brief description of study

Treatments for opioid addiction exist, but effectiveness is compromised when subjects use illicit opiates during treatment. Reuse rates during treatment can be high, and reducing illicit opiate use during treatment has thus recently become a major NIDA policy goal. Our 5-minute battery indicates the numerical probability that a patient will reuse illicit opiates within the next 7-10 days. This project will determine whether introducing an intervention during methadone-based and buprenorphine-based treatment that utilizes our predictive model, reduces use rates (the number of use events per month).


Clinical Study Identifier: s21-00340
ClinicalTrials.gov Identifier: NCT05033028
Principal Investigator: Stephen Ross.
Other Investigator: Paul W. Glimcher.


If you are registered as a volunteer, please log in to contact the study team/express interest in this study.

Contact the research team to learn more about this study.

By clicking "Contact Research Team", your contact information will be sent securely to the research staff associated with the study. You will also receive a copy of this email in your inbox, as well as other notifications to determine your participation status in the study.